Javascript must be enabled to continue!
Behind the Decisions: Managing Health Research Capacity Strengthening Consortia
View through CrossRef
Initiatives aimed at strengthening health research capacity in low and middle-income countries are commonly implemented by consortia. These consortia are increasingly reporting on their programme activities and outputs, but rarely on their management practices. Though investments in such consortia are increasing, there is little evidence in the available literature to guide how they are managed. We thus explored the key management processes adopted by health research capacity strengthening (HRCS) consortia, factors that influence these processes, and their experiences within the DELTAS Africa Programme. We interviewed 23 selected participants: nine consortium directors, ten consortium managers and four funding actors. The consortia had similarities and differences in management processes and practices. Similarities across consortia included factors motivating their establishment and the governing structures used. Differences were observed in decisions related to partner selection, resource sharing and financial management. Consortium leaders often had to tackle diverging alternatives in deciding on appropriate management strategies for their consortia. Understanding the consideration processes and their implications for capacity strengthening can provide guidance for the design and management of HRCS consortia.
Title: Behind the Decisions: Managing Health Research Capacity Strengthening Consortia
Description:
Initiatives aimed at strengthening health research capacity in low and middle-income countries are commonly implemented by consortia.
These consortia are increasingly reporting on their programme activities and outputs, but rarely on their management practices.
Though investments in such consortia are increasing, there is little evidence in the available literature to guide how they are managed.
We thus explored the key management processes adopted by health research capacity strengthening (HRCS) consortia, factors that influence these processes, and their experiences within the DELTAS Africa Programme.
We interviewed 23 selected participants: nine consortium directors, ten consortium managers and four funding actors.
The consortia had similarities and differences in management processes and practices.
Similarities across consortia included factors motivating their establishment and the governing structures used.
Differences were observed in decisions related to partner selection, resource sharing and financial management.
Consortium leaders often had to tackle diverging alternatives in deciding on appropriate management strategies for their consortia.
Understanding the consideration processes and their implications for capacity strengthening can provide guidance for the design and management of HRCS consortia.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Consortia-Based Resource Sharing in Pakistan Academic Libraries: Opportunities, Barriers, and Future Directions
Consortia-Based Resource Sharing in Pakistan Academic Libraries: Opportunities, Barriers, and Future Directions
Resource sharing based on consortia has become an important solution to academic libraries facing the increased costs of information, limited budgets and growing demand of electron...
CALIS, CASHL and library consortium trend in China
CALIS, CASHL and library consortium trend in China
PurposeThis paper aims to provide suggestions and predictions on library consortium development trends in China under new circumstances, as summarised from observations made of CAL...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Metagenomic analysis of microbial consortia native to the Amazon, Highlands, and Galapagos regions of Ecuador with potential for wastewater remediation
Metagenomic analysis of microbial consortia native to the Amazon, Highlands, and Galapagos regions of Ecuador with potential for wastewater remediation
Abstract
Native microbial consortia have been proposed for biological wastewater treatment, but their diversity and function remain poorly understood. This study ...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
ACKNOWLEDGMENTS
ACKNOWLEDGMENTS
The UP Manila Health Policy Development Hub recognizes the invaluable contribution of the participants in theseries of roundtable discussions listed below:
RTD: Beyond Hospit...

